Mankind Pharma Limited will be participating in two key investor conferences in February 2026. The first event is MANTHAN – Systematix India Annual Flagship Conference, scheduled to be held in Mumbai on February 9, 2026. The company officials will engage in one-on-one and group meetings during this conference. Following this, Mankind Pharma will attend the Advantage India - Axis Capital's Flagship India Conference, also in Mumbai, on February 10, 2026. Similar to the previous event, one-on-one and group meetings are planned. The company has stated that no unpublished price-sensitive information will be disclosed during these conferences. The schedule is subject to change based on unforeseen circumstances. This intimation is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the same will be uploaded on the company's website.
